Van Ganse, EricTexier, NathalieDima, Alexandra L.Laforest, LaurentFerrer, MontserratHernandez, GimenaSchuck, StéphaneHerbage, SandrineVial, DelphineDe Bruin, Marijn2015-08-132015-08-132015-06-18Van Ganse, E, Texier, N, Dima, A L, Laforest, L, Ferrer, M, Hernandez, G, Schuck, S, Herbage, S, Vial, D & De Bruin, M 2015, 'Assessment of the safety of long-acting β <inf >2 </inf > -agonists in routine asthma care : The ASTRO-LAB protocol', npj Primary Care Respiratory Medicine, vol. 25, 15040. https://doi.org/10.1038/npjpcrm.2015.40http://hdl.handle.net/2164/4818ASTRO-LAB is funded by the European Commission through the Seventh Framework Program (FP7-Grant Agreement n° 282 593) and gathers seven partners in a Consortium: Université Claude Bernard Lyon 1, University of Nottingham, Kappa Santé SAS, Cegedim Strategic Data Medical Research Limited, University of Amsterdam, Consortio Mar Parc de Salut de Barcelona and Lyon Ingénierie Projets.5926160engSDG 3 - Good Health and Well-beingRA Public aspects of medicinePublic Health, Environmental and Occupational HealthPulmonary and Respiratory MedicineRAJournal article10.1038/npjpcrm.2015.40http://www.scopus.com/inward/record.url?scp=84935005937&partnerID=8YFLogxK25